Price3.62%   +6.68
(After Hours: 191.00 -0.0400 -0.02%)
Jun-07-22 08:42AM Do Options Traders Know Something About Illumina (ILMN) Stock We Don't?Zacks Investment Research
Jun-04-22 09:00AM 3 Cathie Wood Stocks That Could Deliver Monster ReturnsThe Motley Fool
Jun-01-22 09:56AM Illumina's (ILMN) GRAIL to Assess Galleri Test With New DealZacks Investment Research
May-31-22 10:33AM Here's Why Investors Should Retain Illumina (ILMN) Stock NowZacks Investment Research
May-25-22 11:34AM Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVIZacks Investment Research
May-24-22 09:37AM Illumina's (ILMN) Innovations Drive Growth, Cost Woes LingerZacks Investment Research
May-21-22 08:00AM 3 Biotech Stocks With a Cash Pile Higher Than Their ValuationsThe Motley Fool
May-18-22 10:00AM Illumina's (ILMN) GRAIL, Intermountain Healthcare Expand Tie-UpZacks Investment Research
May-16-22 07:53AM 10 Biggest Price Target Changes For MondayBenzinga
May-13-22 10:32AM These 5-Stock Samplers Have Gotten Whacked. And That's OKThe Motley Fool
May-09-22 12:03PM Where Illumina Stands With AnalystsBenzinga
May-07-22 07:53AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
May-06-22 10:55AM Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin DownZacks Investment Research
May-05-22 05:45AM Illumina (ILMN) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research
Apr-29-22 03:35AM 23andMe CEO Anne Wojcicki on Bringing Health Information Directly to PeopleThe Motley Fool
Apr-28-22 08:50AM 2 Reasons to Buy Illumina, and 1 Reason to SellThe Motley Fool
06:20AM This Chart Is Why I'm Not Worried About Guardant HealthThe Motley Fool
Apr-28-22 05:55AM 2 Reasons to Buy Thermo Fisher Scientific, and 1 Reason to SellThe Motley Fool
Apr-25-22 04:04AM Markets Pare Early Losses As Musk-Twitter Agree On Buyout DealBenzinga
11:40AM QGEN or ILMN: Which Is the Better Value Stock Right Now?Zacks Investment Research
Apr-20-22 10:13AM Here's Why You Should Hold on to Illumina (ILMN) Stock For NowZacks Investment Research
Apr-15-22 09:59AM Lessons For Elon Musk: 5 Notorious Failed Hostile TakeoversBenzinga
Apr-14-22 08:44AM Illumina (ILMN) Hurt by Rising Costs, Tough CompetitionZacks Investment Research
Apr-13-22 10:10AM Illumina (ILMN) Launches Genomic Solution Hub in BrazilZacks Investment Research
Apr-12-22 08:25AM 3 Things About Pacific Biosciences of California That Smart Investors KnowThe Motley Fool
Apr-08-22 02:09AM Chemistry X, Infinity, GRAIL: The New Illumina Is A BuySeeking Alpha
Apr-07-22 08:00AM Here Are 2 Pieces of Good News for IlluminaThe Motley Fool
Apr-01-22 04:20AM Why Guardant Health Stock Soared Nearly 10% Higher TodayThe Motley Fool
Mar-29-22 01:03AM Analyst Ratings For IlluminaBenzinga
10:04AM Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022Benzinga
Mar-18-22 10:30AM Illumina (ILMN) Debuts TSO Comprehensive Test in EuropeZacks Investment Research
10:08AM Illumina (ILMN) Invests in Seven Additional Genomics StartupsZacks Investment Research
Mar-14-22 10:02AM Here's Why You Should Retain Illumina (ILMN) Stock For NowZacks Investment Research
Mar-01-22 11:40AM VIR vs. ILMN: Which Stock Should Value Investors Buy Now?Zacks Investment Research
Feb-18-22 01:06AM Top Research Reports for Merck, Shopify & Intercontinental ExchangeZacks Investment Research
Feb-17-22 05:11AM Top Buys From The Best Money Managers (Q4 2021)Seeking Alpha
Feb-16-22 11:06AM Illumina's (ILMN) GRAIL, Point32Health Unite to Offer MCED TestZacks Investment Research
Feb-12-22 02:48AM Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And MoreBenzinga
Feb-11-22 11:11AM What 5 Analyst Ratings Have To Say About IlluminaBenzinga
10:25AM Investors Appear Hesitant As They Digest New Interest Rate NarrativeInvesting.com
Feb-11-22 10:01AM Expert Ratings For IlluminaBenzinga
09:13AM The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPOBenzinga
Feb-11-22 09:12AM Illumina (ILMN) Q4 Earnings Top Estimates, Gross Margin UpZacks Investment Research
07:36AM 10 Biggest Price Target Changes For FridayBenzinga
Feb-11-22 06:23AM A Peek Into The Markets: US Stock Futures Down Following Thursday's PlungeBenzinga
04:07AM 5 Stocks To Watch For February 11, 2022Benzinga
Feb-10-22 08:29AM The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits LillyBenzinga
Feb-09-22 09:13AM Is a Surprise Coming for Illumina (ILMN) This Earnings Season?Zacks Investment Research
Feb-07-22 07:45AM Illumina (ILMN) to Address Nasopharynx Cancer With New PactZacks Investment Research
Feb-06-22 08:22AM The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And MoreBenzinga
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):